Home » Topics » Regulatory

Regulatory
RSS

Mycamine launched in 100 mg vial format

Jan. 16, 2007

Swedish MPA approves Cipralex in OCD

Jan. 15, 2007

Invega approved for treatment of schizophrenia

Dec. 22, 2006

FDA approval for Invanz

Dec. 22, 2006

Pediatric indication approved for Colazal

Dec. 22, 2006

FDA approval for Bio-E-Gel, to be marketed as Elestrin

Dec. 19, 2006

MuGard receives FDA approval

Dec. 14, 2006

Abilify Injection now available

Dec. 14, 2006

Velcade approved for relapsed mantle cell lymphoma

Dec. 12, 2006

Humira receives approval for expanded indication in psoriatic arthritis

Nov. 15, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...